PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11236840-4	2001	Therefore, the aim of the present study was to determine the effect of azide on human recombinant and hepatic CYP2E1, CYP1A2, and CYP3A4.	Azides	71-76	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	118-124	
30553624-4	2019	Structural evolution of 37 produced the azide-containing cis-49a, which had good properties in three important respects: (1) selectivity for CYP1B1 over CYP1A1 and CYP1A2 (120-times and 150-times, respectively), (2) greater inhibitory potency of >2 times that of ANF, and (3) improved solubility.	Azides	40-45	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	164-170	
11236840-5	2001	METHODS AND RESULTS: Concentrations of sodium azide as low as 0.1 mM markedly inhibited the specific ethanol oxidation (mean +/- SEM) by recombinant CYP1A2 and CYP3A4 expressed in HepG2 cells (to 16 +/- 1% and 22 +/- 2% of control without azide, respectively; p < 0.01).	Azides	46-51	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	149-155	
11236840-7	2001	Similarly, in human liver microsomes (n = 6), 0.1 mM azide strongly inhibited CYP1A2-dependent (to 25 +/- 2%) and CYP3A4-dependent (to 15 +/- 2%) ethanol oxidation, whereas CYP2E1 was inhibited only at 10 mM azide (to 60 +/- 10%).	Azides	53-58	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	78-84